Nichols Blake, Kubis Sherri, Hewlett Jennifer, Yehya Nadir, Srinivasan Vijay
1Division of Pediatric Critical Care, Children's Medical Center, Dallas, TX. 2Department of Nursing, Children's Hospital of Philadelphia, Philadelphia, PA. 3Division of Clinical Pharmacy, Children's Hospital of Philadelphia, Philadelphia, PA. 4Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA. 5Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Pediatr Crit Care Med. 2017 Sep;18(9):e406-e414. doi: 10.1097/PCC.0000000000001237.
The 2012 Surviving Sepsis Campaign pediatric guidelines recommend stress dose hydrocortisone in children experiencing catecholamine-dependent septic shock with suspected or proven absolute adrenal insufficiency. We evaluated whether stress dose hydrocortisone therapy in children with catecholamine dependent septic shock correlated with random serum total cortisol levels and was associated with improved outcomes.
Retrospective cohort study.
Non-cardiac PICU.
Critically ill children (1 mo to 18 yr) admitted between January 1, 2013, and December 31, 2013, with catecholamine dependent septic shock who had random serum total cortisol levels measured prior to potential stress dose hydrocortisone therapy.
None.
The cohort was dichotomized to random serum total cortisol less than 18 mcg/dL and greater than or equal to 18 mcg/dL. Associations of stress dose hydrocortisone with outcomes: PICU mortality, PICU and hospital length of stay, ventilator-free days, and vasopressor-free days were examined. Seventy children with catecholamine-dependent septic shock and measured random serum total cortisol levels were eligible (16% PICU mortality). Although 43% (30/70) had random serum total cortisol less than 18 μg/dL, 60% (42/70) received stress dose hydrocortisone. Children with random serum total cortisol less than 18 μg/dL had lower severity of illness and lower Vasopressor Inotrope Scores than those with random serum total cortisol greater than or equal to 18 μg/dL (all p < 0.05). Children with stress dose hydrocortisone had higher severity of illness and PICU mortality than those without stress dose hydrocortisone (all p < 0.05). Mean random serum total cortisol levels were similar in children with and without stress dose hydrocortisone (21.1 vs 18.7 μg/dL; p = 0.69). In children with random serum total cortisol less than 18 μg/dL, stress dose hydrocortisone was associated with greater PICU and hospital length of stay and fewer ventilator-free days (all p < 0.05). In children with random serum total cortisol greater than 18 μg/dL, stress dose hydrocortisone was associated with greater PICU mortality and fewer ventilator-free days and vasopressor-free days (all p < 0.05).
Stress dose hydrocortisone therapy in children with catecholamine-dependent septic shock correlated more with severity of illness than random serum total cortisol levels and was associated with worse outcomes, irrespective of random serum total cortisol levels.
2012年拯救脓毒症运动儿科指南推荐,对于怀疑或已证实存在绝对肾上腺功能不全且依赖儿茶酚胺的脓毒性休克患儿,应给予应激剂量的氢化可的松。我们评估了依赖儿茶酚胺的脓毒性休克患儿接受应激剂量氢化可的松治疗是否与随机血清总皮质醇水平相关,以及是否与改善的预后相关。
回顾性队列研究。
非心脏重症监护病房。
2013年1月1日至2013年12月31日期间收治的患有依赖儿茶酚胺的脓毒性休克的危重症儿童(1个月至18岁),在接受潜在应激剂量氢化可的松治疗前测量了随机血清总皮质醇水平。
无。
将队列分为随机血清总皮质醇低于18 mcg/dL和大于或等于18 mcg/dL两组。研究应激剂量氢化可的松与预后的关联:包括儿科重症监护病房(PICU)死亡率、PICU和住院时间、无呼吸机天数和无血管活性药物天数。70例患有依赖儿茶酚胺的脓毒性休克且测量了随机血清总皮质醇水平的儿童符合条件(PICU死亡率为16%)。尽管43%(30/70)的患儿随机血清总皮质醇低于18 μg/dL,但60%(42/70)接受了应激剂量的氢化可的松治疗。随机血清总皮质醇低于18 μg/dL的患儿,其疾病严重程度和血管活性药物-正性肌力药物评分低于随机血清总皮质醇大于或等于18 μg/dL的患儿(所有p<0.05)。接受应激剂量氢化可的松治疗的患儿,其疾病严重程度和PICU死亡率高于未接受应激剂量氢化可的松治疗的患儿(所有p<0.05)。接受和未接受应激剂量氢化可的松治疗的患儿,其平均随机血清总皮质醇水平相似(21.1 vs 18.7 μg/dL;p = 0.69)。在随机血清总皮质醇低于18 μg/dL的患儿中,应激剂量氢化可的松与更长的PICU和住院时间以及更少的无呼吸机天数相关(所有p<0.05)。在随机血清总皮质醇大于18 μg/dL的患儿中,应激剂量氢化可的松与更高的PICU死亡率以及更少的无呼吸机天数和无血管活性药物天数相关(所有p<0.05)。
对于依赖儿茶酚胺的脓毒性休克患儿,应激剂量氢化可的松治疗与疾病严重程度的相关性大于与随机血清总皮质醇水平的相关性,且与更差的预后相关,与随机血清总皮质醇水平无关。